1月14日【港股Podcast】恆指、騰訊、小米、藥明生物 、攜程集團、阿里健康
Ge Long Hui·2026-01-15 12:35

Group 1: Market Overview - The Hang Seng Index (HSI) closed at 26,999 points on January 14, with investors divided on future movements, some expecting a rise to 27,200 points while others are cautious about breaking the 27,000 mark [1][2] - Resistance is noted at 27,300 points, with potential for an increase to 27,900 points if this level is surpassed, suggesting investors should consider longer-dated products for bearish positions [2][3] - Technical signals indicate a predominance of sell signals, with 9 sell signals compared to 5 buy signals, suggesting a short-term selling trend [3][7] Group 2: Individual Stock Analysis - Tencent Holdings (00700.HK) closed at 633 HKD, near its upper Bollinger Band, with 8 sell signals and 5 buy signals indicating a bearish outlook; potential support levels are at 618 HKD and 601 HKD [9][10] - Xiaomi Group (01810.HK) closed at 37.78 HKD, showing a weak performance; support is at 37 HKD, with potential further decline to 35.8 HKD; however, there are more buy signals suggesting a possible recovery [15][16] - WuXi Biologics (02269.HK) has shown strong performance, rising from around 31 HKD to 40 HKD, with resistance at 40.4 HKD and potential for further gains to 45.5 HKD, though sell signals are currently more prevalent [22][24] - Trip.com Group (09961.HK) experienced a significant drop to 569.5 HKD, with increased trading volume; the technical signals are neutral, suggesting investors should wait for clearer direction before buying [25][30] - Alibaba Health (00241.HK) closed at 7.78 HKD after a strong rise, but with sell signals dominating, a short-term correction is anticipated after breaking through key resistance levels [32][36]